NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.

NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy.

OBJECTIVE: To validate the hypothesis that men displaying serum prostate-specific antigen (PSA) slopes ≤ 2.0 pg/mL/mo after prostatectomy, measured using a new immuno-polymerase chain reaction diagnostic test (NADiA ProsVue), have a reduced risk of clinical recurrence as determined by positive biops...

Full description

Bibliographic Details
Main Authors: Moul, J, Lilja, H, Semmes, O, Lance, R, Vessella, R, Fleisher, M, Mazzola, C, Sarno, M, Stevens, B, Klem, R, McDermed, J, Triebell, M, Adams, T
Format: Journal article
Language:English
Published: 2012

Similar Items

Similar Items